We're thrilled to announce that, with the incredible support of our community and a generous angel donor, we've reached our fundraising goal for the third year in a row. This wouldn't have been possible without each and every one of you who donated, shared, and supported our cause. Your kindness and generosity mean the world to us and to those fighting cancer. Thank you from the bottom of our hearts. #FierceSistersFightCancer #CancerFighters #CommunitySupport #Gratitude #ThankYou #CancerResearch #FundraisingSuccess
Fierce Sisters Fight Cancer
资金募集机构
Los Angeles,CA 53 位关注者
Fiercely fighting for a cancer-free future
关于我们
Help the FIERCE SISTERS FIGHT CANCER at the LA Marathon Charity Challenge. Walk, run, or donate to the cause! Make a TAX-DEDUCTIBLE donation to benefit the Ovarian Cancer Research Program at UCLA's Jonsson Comprehensive Cancer Center. https://www.justgiving.com/campaign/fiercesistersfightcancer2024 Fierce Sisters Fight Cancer Story The journey started the day Elisabeth received a Stage IVb Ovarian Cancer diagnosis. From symptoms to advanced high-grade serous carcinoma, it was a 22 terrifying days. Soon after, both Elisabeth and her sister Susan were identified as BRCA1 mutation carriers. Susan underwent preventive surgeries only to discover that she, too had the beginnings of this disease. It is hard to express the despair and powerlessness one feels to learn that there is no "cure" for ovarian cancer. Only 17% of advanced-stage patients are still alive by year five, and of those patients who do survive, there is a 90-95% recurrence rate. Also, BRCA1 carriers have a very high lifetime risk for breast and ovarian cancer, and there is no early detection test. Their despair turned to hope when they met Dr. Gottfried E. Konecny, an internationally recognized leader in ovarian cancer research, a physician-scientist, and a professor of medicine at the Geffen School of Medicine at UCLA. Given his extensive research, Dr. Konecny put Elisabeth on a life-saving clinical trial of PARP-Inhibitors, a new targeted drug treatment known to not only extend the life of advanced ovarian cancer patients. It also holds the promise of treating ovarian cancer for the first time as a chronic disease rather than as a death sentence! Our goal is to support Dr. Konecny's vital research at the UCLA Translational Oncology Lab in developing a method for early detection and to support his research into PARP-Inhibitors and other novel targeted treatment therapies.
- 网站
-
https://www.fiercesistersfightcancer.org/
Fierce Sisters Fight Cancer的外部链接
- 所属行业
- 资金募集机构
- 规模
- 2-10 人
- 总部
- Los Angeles,CA
- 类型
- 非营利机构
- 创立
- 2021
地点
-
主要
US,CA,Los Angeles,91316